NCT03571321 Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE1
NCT03275636 Haploidentical Donor vs mMUD in Hematological Malignancies Status COMPLETED Phase PHASE2/PHASE3
NCT03198234 Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders Status TERMINATED Phase PHASE1
NCT02861209 Collaborative Network to Take Responsibility for Oral Anticancer Therapy Status UNKNOWN Phase NA
NCT02795520 Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous Leukemia Status TERMINATED Phase PHASE1/PHASE2
NCT02776605 Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia Status UNKNOWN Phase PHASE2
NCT02528435 Understanding Methotrexate Induced Gastrointestinal Intolerance in Juvenile Idiopathic Arthritis and Childhood Leukemia Status COMPLETED Phase N/A
NCT02315612 Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies Status COMPLETED Phase PHASE1
NCT02133599 Prediction of Excretion and Toxicity of High Dose Methotrexate in Children and Adolescents With ALL Status COMPLETED Phase NA
NCT01593696 Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma Status COMPLETED Phase PHASE1
NCT01532635 A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives Status TERMINATED Phase PHASE2
NCT01319864 POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients Status COMPLETED Phase PHASE1
NCT01230788 Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia Status TERMINATED Phase NA
NCT01204164 Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies Status COMPLETED Phase PHASE1
NCT01012492 Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT Status COMPLETED Phase PHASE2